Pharmacological management of obesity: an Endocrine Society clinical practice guideline
J. clin. endocrinol. metab; 100 (2), 2015
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
Obesidad/tratamiento farmacológico, Diabetes Mellitus/etiología, Depresión/etiología, Serotoninérgicos/uso terapéutico, Dopaminérgicos/uso terapéutico, Norepinefrina/uso terapéutico, Fentermina/uso terapéutico, Bupropión/uso terapéutico, Naltrexona/uso terapéutico, Péptido 1 Similar al Glucagón/agonistas